Avesi Partners invests in New Age Medical to scale spinal surgery supply hub

# What happened Avesi Partners announced a growth investment in New Age Medical, a MedTech hub focused on the spinal surgery market. The deal pairs Avesi with Kevin Bly, New Age's founder and CEO, plus the company's existing management team.

# Why it matters New Age positions itself between device manufacturers, sales representatives, hospitals and ambulatory surgery centers (ASCs), and surgeons. The company's model aims to reduce supply chain complexity, enable vendor consolidation for hospitals and ASCs, and speed access to spinal implants, orthobiologics and related products for surgeons and patients.

Avesi is an investment firm with offices in Stamford, CT and Richmond, VA, and reported assets under management of over $2.2 billion. The firm focuses on lower-middle market, privately held and family-owned businesses in healthcare services, healthcare technology and business services.

# Company scale and reach New Age Medical, founded in 2012 and headquartered in St. Louis, works nationwide with:

• 85+ original equipment manufacturers (OEMs)
• 100+ medical device sales representatives
• 200+ hospitals and ambulatory surgery centers
• 350+ surgeons

Those figures are central to New Age's pitch: aggregate relationships across manufacturers, reps and facilities allow the company to act as a single hub that reduces administrative and operational friction for clients.

# What both parties say

Pete Tedesco, Managing Director at Avesi, described New Age as delivering value that helps health systems lower administrative burden while maintaining care standards. Chris Laitala, Managing Partner at Avesi, pointed to New Age's track record and relationship strength across the ecosystem as differentiators and said Avesi will work alongside management to expand reach and capabilities.

# Expected focus after the investment Avesi identified New Age as operating in a large and growing market with room to expand into new specialties and geographies. The partnership signals plans to:

• Scale distribution and facility coverage
• Expand services into adjacent specialty markets beyond spinal surgery
• Leverage Avesi's healthcare operating resources to accelerate growth

# Why buyers and facilities might care Hospitals and ASCs that seek vendor consolidation and simpler supply chains may find New Age's hub model useful. For surgeons and reps, the value proposition centers on faster access to the latest OEM products without as much administrative coordination.

# Background on the organizations

# Bottom line The deal is an institutional growth investment intended to accelerate New Age Medical's national reach and operational capabilities within the spinal surgery supply chain, backed by an investor that targets healthcare services and technology platforms.